BOCIC(SH:601696) Xin Lang Cai Jing·2025-11-17 02:28Group 1 - The core point of the news is that Aosaikang's stock price has dropped by 5.18%, currently trading at 18.67 yuan per share, with a total market capitalization of 17.329 billion yuan [1] - Aosaikang Pharmaceutical Co., Ltd. is located in Jiangning Science Park, Nanjing, and was established on December 24, 1996. The company was listed on May 15, 2015, and its main business involves the research, production, and sales of drugs in the fields of digestion, anti-tumor, and others [1] - The revenue composition of Aosaikang's main business includes: anti-tumor drugs 38.28%, anti-infection drugs 24.74%, chronic disease drugs 21.65%, digestive drugs 12.33%, and others 2.34% [1] Group 2 - According to data from the top ten heavy stocks of funds, one fund under Bank of China Securities holds Aosaikang as a significant investment. The fund, Bank of China Securities Health Industry Mixed Fund (002938), held 340,000 shares, accounting for 4.43% of the fund's net value, ranking as the tenth largest heavy stock [2] - The Bank of China Securities Health Industry Mixed Fund (002938) was established on September 7, 2016, with a current scale of 159 million yuan. Year-to-date, it has achieved a return of 43.61%, ranking 1391 out of 8213 in its category [2] - The fund manager of the Bank of China Securities Health Industry Mixed Fund is Li Mingwei, who has been in the position for 2 years and 270 days, with the fund's total asset scale at 159 million yuan [3]